Cargando…
Adjunctive therapies and immunomodulating agents for severe influenza
The value of adjunctive immunomodulatory therapies in treating severe influenza and other respiratory viral infections remains uncertain. Although often used, systemic corticosteroids may increase the risk of mortality and morbidity (e.g. secondary infections) in severe influenza and other viral inf...
Autores principales: | Hui, David S. C., Lee, Nelson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492653/ https://www.ncbi.nlm.nih.gov/pubmed/24215382 http://dx.doi.org/10.1111/irv.12171 |
Ejemplares similares
-
Adjunctive therapies and immunomodulatory agents in the management of severe influenza
por: Hui, David S., et al.
Publicado: (2013) -
Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023) -
The role of adjuvant immunomodulatory agents for treatment of severe influenza
por: Hui, David S., et al.
Publicado: (2018) -
The plant-based immunomodulator curcumin as a potential candidate for the development of an adjunctive therapy for cerebral malaria
por: Mimche, Patrice N, et al.
Publicado: (2011) -
Tofacitinib as an Adjunct Immunomodulator for Treatment of a Patient with Severe COVID-19: A Case Report
por: Shrestha, Gentle Sunder, et al.
Publicado: (2021)